RTOG 0848. A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
Mitchel Fromm, MD
McDowell Cancer Research at 330-344-6348
RTOG 1201. A Phase II Randomized Trial of High versus Standard Intensity Local or Systemic Therapy for Unresectable Pancreatic Cancer
CTSU E2211. A Randomized Phase II Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors
Esther Rehmus, MD
Akron General Medical Center 1 Akron General Avenue (Formerly 400 Wabash Avenue) Akron, OH 44307 330-344-6000 1-800-221-4601 © 2014 Akron General Health System
This site complies with the HONcode standard for trustworthy health information: verify here.